These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24350256)

  • 1. Role of stenting for intracranial atherosclerosis in the post-SAMMPRIS era.
    Ding D; Starke RM; Crowley RW; Liu KC
    Biomed Res Int; 2013; 2013():304320. PubMed ID: 24350256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.
    Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG
    J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
    Mekonnen EA; Tekle WG; Desai SK; Hassan AE
    Interv Neuroradiol; 2023 Aug; 29(4):459-465. PubMed ID: 35331035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
    Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
    J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS.
    Miao Z; Song L; Liebeskind DS; Liu L; Ma N; Wang Y; Mo D; Gao F; Zhao X; Dong K; Zhang D; Gao P
    J Neurointerv Surg; 2015 May; 7(5):331-5. PubMed ID: 24759694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Advances in Endovascular Treatment of Intracranial Atherosclerotic Disease and Future Prospective.
    Jafari M; Nguyen TN; Ortega-Gutierrez S; Hussain MS; Hassan AE; Ikram A; Eliyas JK; Rodriguez GJ; Divani AA
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105556. PubMed ID: 33360252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
    Li A; Ye Z; Zhou W; Qin C
    Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.
    Fiorella D; Chow MM; Anderson M; Woo H; Rasmussen PA; Masaryk TJ
    Neurosurgery; 2007 Aug; 61(2):236-42; discussion 242-3. PubMed ID: 17762735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent.
    Vajda Z; Güthe T; Perez MA; Kurre W; Schmid E; Bäzner H; Henkes H
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):346-52. PubMed ID: 22869043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease.
    Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J
    Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial atherosclerosis update for neurointerventionalists.
    Alexander MJ; Yu W
    J Neurointerv Surg; 2024 Apr; 16(5):522-528. PubMed ID: 37295944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).
    Derdeyn CP; Fiorella D; Lynn MJ; Turan TN; Cotsonis GA; Lane BF; Montgomery J; Janis LS; Chimowitz MI;
    Stroke; 2017 Jun; 48(6):1501-1506. PubMed ID: 28455321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.
    Miao Z; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Wang Y; Wang Y;
    Stroke; 2015 Oct; 46(10):2822-9. PubMed ID: 26286544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon-mounted stents for acute intracranial large vessel occlusion secondary to presumed atherosclerotic disease: evolution in an era of supple intermediate catheters.
    Gross BA; Desai SM; Walker G; Jankowitz BT; Jadhav A; Jovin TG
    J Neurointerv Surg; 2019 Oct; 11(10):975-978. PubMed ID: 31092560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
    Marks MP
    Stroke; 2012 Feb; 43(2):580-4. PubMed ID: 22246690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial.
    Quintero-Consuegra MD; Toscano JF; Babadjouni R; Nisson P; Kayyali MN; Chang D; Almallouhi E; Saver JL; Gonzalez NR
    Neurosurgery; 2021 Mar; 88(4):E312-E318. PubMed ID: 33469657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.